Home › Funds › LVW Advisors, LLC › GILD

LVW Advisors, LLC position in GILD

GILEAD SCIENCES INC · Health Care

LVW Advisors, LLC reported holding 21,749 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$3.2M, representing 0.27% of its reported portfolio and ranking #50 among its reported holdings. LVW Advisors, LLC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)21.75K sh
Reported value held$3.24M
Portfolio Weight0.27%
First reportedQ3 2023
Last changeReduce
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How LVW Advisors, LLC's GILD position evolved

LVW Advisors, LLC first disclosed a stake in GILD in Q3 2023 at 11,215 shares (US$840K). The position peaked in Q1 2026 at 23,548 shares, worth US$3.3M. Across 13 filings, LVW Advisors, LLC increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 21,749 shares valued at US$3.2M — a reduction of -1,647 shares quarter over quarter.. Notable position changes include a 46% increase in Q4 2023 (shares fell 9% over the following quarter), a 56% increase in Q1 2024 (shares fell 6% over the following quarter), a 34% trim in Q2 2024 (shares rose 22% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 11.21K $840.45K New
Q4 2023 16.36K $1.33M Add
Q1 2024 25.58K $1.87M Add
Q2 2024 16.88K $1.16M Reduce
Q3 2024 18.82K $1.58M Add
Q4 2024 18.82K $1.74M Hold
Q1 2025 18.34K $2.05M Reduce
Q2 2025 19.68K $2.18M Add
Q3 2025 19.95K $2.21M Add
Q4 2025 21.82K $2.68M Add
Q1 2026 23.55K $3.28M Add
Q2 2026 23.40K $2.96M Reduce
Q3 2026 21.75K $3.24M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has LVW Advisors, LLC held GILD?

LVW Advisors, LLC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is LVW Advisors, LLC's current position in GILD?

As of Q3 2026, LVW Advisors, LLC holds 21.75K shares of GILD (GILEAD SCIENCES INC), valued at $3.24M, representing 0.27% of its reported portfolio and ranking #50.

Has LVW Advisors, LLC been buying or selling GILD?

In the latest 13F filing (Q3 2026), LVW Advisors, LLC reduced its position in GILD. The position peaked in Q1 2026 at 23.55K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.